Bossuyt, P., Ferrante, M., Baert, F., Danese, S., Feagan, B. G., Loftus Jr, E. V., Panés, J., Peyrin-Biroulet, L., Ran, Z., Armuzzi, A., D'Haens, G. R., Song, A., Neimark, E., Liao, X., Zhou, Q., Berg, S., Wallace, K., & Panaccione, R. (n.d.). oP36 Risankizumab therapy induces improvements in endoscopic endpoints in patients with Moderate-to-Severe Crohn's Disease: Results from the phase 3 ADVANCE and MOTIVATE studies. Journal of Crohn's and colitis, 15, S033–S034. http://access.bl.uk/ark:/81055/vdc_100130765543.0x000011